CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) today announced that, based on a preliminary count provided by its proxy solicitor, it appears the Company’s stockholders elected Robert W. Pangia, William D. Young and Alexander J. Denner, Ph.D., to the Biogen Idec Board of Directors. Based on that count, results on the election of the fourth director were too close to call. The Company will rely on the tabulation of votes by the Company’s independent inspector of elections, IVS Associates, before announcing the remaining director to serve on the Board.
